Sarah Haylock-Jacobs

Head of Clinical Operations

BugBiome

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sarah Haylock-Jacobs is the Head of Clinical Operations at BiomeBank in Australia. Her research focuses on hepatitis B and C, with recent publications emphasizing the cost-effectiveness of treatment options and clinical outcomes of viral infections. She has contributed significantly to studies on fecal microbiota transplantation and the impact of antiretroviral therapy on co-infected patients.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Georgine Cua

The University of British Columbia

CANADA

View details

Sofia Bartlett

Adjunct Professor

The University of British Columbia

CANADA

View details

Stephen Congly

University of Calgary

CANADA

View details

Mang Ma

Professor

CANADA

View details

Hin Hin Ko

The University of British Columbia

CANADA

View details

Richard Urbanowicz

Lecturer in Infection Immunology

University of Liverpool

UNITED KINGDOM

View details

Karen Doucette

Professor

University of Alberta

CANADA

View details

Carla S. Coffin

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Haylock-Jacobs

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A real-world retrospective single-centre study of the cost-effectiveness and long-term outcomes of pegylated interferon for chronic hepatitis B

Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation

Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)

Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study

Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada

Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue

Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America

Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study.

Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Collaborators (8)

Georgine Cua

Sofia Bartlett

Stephen Congly

Mang Ma

Hin Hin Ko

Richard Urbanowicz

Karen Doucette

Carla S. Coffin

Make your next move.